Peptide fractions promoting growth and synthesis of desired product(s) into cell and/or tissue culture

Details for Australian Patent Application No. 2005315612 (hide)

Owner Pierre Fabre Medicament Centre National de la Recherche Scientifique (CNRS)

Inventors Farges-Haddani, Berangere; Goergen, Jean-Louis; Marc, Annie

Agent Griffith Hack

Pub. Number AU-A-2005315612

PCT Pub. Number WO2006/064020

Priority 0413250 14.12.04 FR

Filing date 14 December 2005

Wipo publication date 22 June 2006

International Classifications

C12N 5/00 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines

C12N 5/02 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Propagation of single cells or cells in suspension

C12N 5/06 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines -

Event Publications

5 July 2007 PCT application entered the National Phase

  PCT publication WO2006/064020 Priority application(s): WO2006/064020

15 May 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005315613-Repair of coated substrates

2005315608-Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and HMG CoA reductase inhibitors